1432503-87-1

Basic information

• Product Name: methyl 4-(2-methoxy-2-oxoethyl)-2-(2,4,5-trifluorobenzyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide
• Synonyms: methyl 4-(2-methoxy-2-oxoethyl)-2-(2,4,5-trifluorobenzyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide
• CAS NO: 1432503-87-1
• Molecular Weight: 458.415
• Mol File: 1432503-87-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 4-(2-methoxy-2-oxoethyl)-2-(2,4,5-trifluorobenzyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-(2-methoxy-2-oxoethyl)-2-(2,4,5-trifluorobenzyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide(1432503-87-1)
• EPA Substance Registry System: methyl 4-(2-methoxy-2-oxoethyl)-2-(2,4,5-trifluorobenzyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide(1432503-87-1)

Safety Data

• Hazardous Substances Data: 1432503-87-1(Hazardous Substances Data)

Upstream product

• 71254-63-2 7-methyl-3-oxo-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide 
• 1432503-75-7 methyl 4-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide 
• 157911-56-3 2,4,5-trifluorobenzyl bromide 
• 1432503-69-9 methyl 4-(2-methoxy-2-oxoethyl)-4H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide 
• 945388-28-3 methyl 4H-benzo[e][1,2,4]thiadiazine-7-carboxylate-1,1-dioxide 
• 945388-03-4 4H-benzo[e][1,2,4]thiadiazine-7-carboxylic acid-1,1-dioxide 
• 89694-28-0 4-amino-3-sulfamoylbenzoic acid 
• 201224-76-2 3-oxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-carboxylic acid 1,1-dioxide 
• 106-49-0 p-toluidine 

Downstream Products

• 1432504-02-3 C₁₇H₁₃F₃N₂O₆S 

Relevant articles and documents

Effect of C7 Modifications on Benzothiadiazine-1,1-dioxide Derivatives on Their Inhibitory Activity and Selectivity toward Aldose Reductase

The development and progression of chronic complications in diabetic patients, such as retinopathy, nephropathy, neuropathy, cataracts, and stroke, are related to the activation and/or overexpression of aldose reductase (ALR2), which is a member of the al